HomeFEATURED

FEATURED

Confluent Medical Technologies Expands Relationship with Allegheny Technologies

Confluent Medical Technologies Inc. today announced an expansion of its supply agreement with Allegheny Technologies related to the manufacture and supply of ELI Nitinol.

ICI and Viral Sign a Form a Strategic Alliance

ICI and Viral Sign strategic alliance will allow both companies to supply advanced screening systems intended to help slow the spread of infectious disease, including COVID-19. 

Eitan Medical Launches UK Operation

Eitan Medical UK launches with a team of specialists in clinical support, integrated care support and operations management.

CATHIS Smart Portable Endovascular Simulator System Displays All types of Endovascular Interventions In any Medical Field

CATHIS® Smart displays all types of endovascular intervention in any medical field, however complex and challenging they may be. The system is particularly appropriate for neuroradiology, cardiology, radiology, angiology and pneumology.

Soliton Announces Collaboration with US Navy to Conduct Proof-of-Concept Study for Fibrotic Scars

The study will be a US-based, single-center, prospective trial, examining a maximum of 25 patients.

Philips and Vithas Sign a 5 Year Strategic Agreement

"This new alliance with Philips integrates cutting-edge technology, healthcare excellence, innovation, and research, which are the fundamental pillars on which we support our commitment to always seek the best experience for our patients, said, Dr. Pedro Rico, CEO of Vithas Group.

WIDEX MOMENT ™ Hearing Aids Named Digital Trends ‘Tech for Change 2021’ Award Winner

WIDEX MOMENT was selected for having pioneered the first digital hearing aid to incorporate dual artificial intelligence engines to improve real-time listening.

ALung Technologies Reports Hemolung® RAS Used to Treat More than 75 COVID-19 Patients

ALung Technologies, Inc. announced that it has now treated more than 75 COVID-19 patients, and that it is experiencing increasing demand for the Hemolung RAS as a result of the current pandemic.

SENSEI, 1st Robotic Gamma Probe Receives CE Mark

SENSEI has been designed for intra-operative detection of sentinel lymph nodes as well as cancer metastasis through the lymphatic system.
Exit mobile version